IRIS
MUSI, Gennaro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 506
AS - Asia 225
EU - Europa 179
AF - Africa 15
Totale 925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 495
SG - Singapore 134
IT - Italia 93
NL - Olanda 51
CN - Cina 49
VN - Vietnam 28
CI - Costa d'Avorio 14
CA - Canada 11
IN - India 7
DE - Germania 5
FI - Finlandia 5
GB - Regno Unito 5
GR - Grecia 4
IE - Irlanda 4
FR - Francia 3
LT - Lituania 3
AT - Austria 2
HK - Hong Kong 2
TR - Turchia 2
BE - Belgio 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IR - Iran 1
MA - Marocco 1
NP - Nepal 1
PK - Pakistan 1
SE - Svezia 1
Totale 925
Salva come PNG Salva come JPEG
Città #
Singapore 120
Chandler 100
Amsterdam 50
Naples 38
Santa Clara 33
Ashburn 29
Dong Ket 28
Millbury 26
Des Moines 18
Lawrence 18
Beijing 16
Boston 12
Ottawa 11
Nanjing 10
Princeton 7
Wilmington 7
Milan 5
Napoli 5
Dublin 4
Jiaxing 4
Redwood City 4
Abidjan 3
Boardman 3
Dallas 3
Dearborn 3
Fairfield 3
Helsinki 3
Kronberg 3
Marijampolė 3
Norwalk 3
Pune 3
Changsha 2
Fort Worth 2
Frankfurt am Main 2
Hebei 2
Hong Kong 2
Istanbul 2
Kolkata 2
Lappeenranta 2
Locate di Triulzi 2
Phoenix 2
Piana 2
Romainville 2
Rome 2
Rovereto 2
Shenyang 2
Woodbridge 2
Alba 1
Ardabil 1
Arezzo 1
Augusta 1
Brno 1
Brussels 1
Buffalo 1
Cambridge 1
Delhi 1
Edinburgh 1
Fagnano Olona 1
Houston 1
Karachi 1
Kathmandu 1
London 1
Manassas 1
Mugnano di Napoli 1
Nanchang 1
New York 1
Rabat 1
San Giorgio a Cremano 1
San Giuseppe Vesuviano 1
Seattle 1
Sorrento 1
Springfield 1
Tianjin 1
Vienna 1
Washington 1
Zagreb 1
Totale 636
Salva come PNG Salva come JPEG
Nome #
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 55
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 46
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 41
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 41
Beyond PSA: The Role of Prostate Health Index (phi) 38
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 38
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 36
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 35
The impact of surgery for lower urinary tract symptoms/benign prostatic enlargement on both erectile and ejaculatory function: a systematic review 34
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 34
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 33
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 33
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 32
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 32
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 30
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 29
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 28
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center 27
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study 27
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 27
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 26
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 26
Prostate cancer radiogenomics—from imaging to molecular characterization 26
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 23
Patient Selection for Active Surveillance in the Multi-parametric Magnetic Resonance Imaging Era: A Step Forward in a Rapidly Evolving Field 22
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 19
Contemporary sex-specific analysis of the association of marital status with cancer-specific mortality in primary urethral carcinoma patients 16
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 13
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 12
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients 12
Radiomics in prostate cancer: an up-to-date review 10
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 10
Contemporary conditional cancer‐specific survival rates in surgically treated nonmetastatic primary urethral carcinoma 9
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 9
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 9
The European Network for the Study of Adrenal Tumors Staging System (2015): A United States Validation 8
The Association between Urinary Diversion Type and Other-Cause Mortality in Radical Cystectomy Patients 7
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 7
Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls 6
Telemedicine and social media: A contemporary analysis of the most shared content by internet users 6
Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients 5
Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity 5
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma 4
Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis 4
Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma Patients 4
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma 3
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality–free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients 3
Regional differences in upper tract urothelial carcinoma patients across the United States 3
Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma 2
Totale 1.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 0 1 3 7 3 5 10 7 6
2020/202160 5 0 1 0 2 13 1 1 4 0 2 31
2021/2022153 6 1 2 0 2 1 4 4 2 17 57 57
2022/2023270 25 6 11 6 43 30 0 30 44 54 19 2
2023/2024207 4 34 39 11 5 12 3 28 6 2 39 24
2024/2025220 40 67 39 15 59 0 0 0 0 0 0 0
Totale 1.005